Back to DANSKE BANK A/S DANSKE BANK A/S

TOVXTOVX
8 quarters

Position history for DANSKE BANK A/SDANSKE BANK A/S's holdings in THERIVA BIOLOGICS INC

Yes. Danske Bank holds 1 shares of TOVX (Theriva Biologics) as of its Q2 2026 13F filing. The share count is unchanged from Q1 2026. Danske Bank has held TOVX since Q3 2024, across 8 quarterly 13F filings.

Current Value

$0

Current Shares

1

Total Value Change

-$1

Total Shares Change

0

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
1
0.0%
$00.0%$0.25
0
2026-Q1
Unchanged
1
0.0%
$00.0%$0.19
0
2025-Q4
Unchanged
1
0.0%
$00.0%$0.20
0
2025-Q3
Unchanged
1
0.0%
$00.0%$0.40
0
2025-Q2
Unchanged
1
0.0%
$00.0%$0.43
0
2025-Q1
Unchanged
1
0.0%
$10.0%$1.14
0
2024-Q4
Unchanged
1
0.0%
$20.0%$1.50
0
2024-Q3
New
1
-
$10.0%$1.49
17

Other major holders of TOVX: VANGUARD CAPITAL MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, JANE STREET GROUP, LLC, VANGUARD FIDUCIARY TRUST CO

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used